Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT04827758
Brief Summary:
The main objective of this study is to determine the prevalence of sarcopenia in patients hospitalized in the follow-up care and rehabilitation units of the geriatrics department of the Mulhouse French hospital.
Detailed Description:
Secondary objectives
1. To assess the performance of the SARC-F questionnaire to screen for sarcopenia ;
2. To describe the characteristics of sarcopenic patients hospitalized in each follow-up care and rehabilitation unit (i.e. day hospital, full hospitalization);
3. To identify predictive factors of sarcopenia;
4. To determine, in the subgroup of patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), the evolution of sarcopenia between admission and discharge of the following variables :
1. muscle strength,
2. muscle mass,
3. functional ability,
4. dependency.
Conduct of research
After receiving the written consent of the study participant, all of the following tests and questionnaires will be performed :
* SARC-F questionnaire,
* measurement of muscle strengh by a grip test,
* measurement of muscle mass by impedancemetry (ASM/size2),
* 4-meter walking speed test,
* Timed-Up and Go (TUG) test,
* ADL (Activities of Daily Living) and IADL (Instrumental Activities of Daily Living) questionnaires.
For patients in day hospital care, the study will end upon completion of these tests.
For patients hospitalized in the conventional follow-up care and rehabilitation unit (i.e. full hospitalization), a follow-up visit will be scheduled within 72 hours prior to the patient's discharge from the service, or at 3 months of hospitalization. The following tests and questionnaires will be performed during this visit:
* measurement of muscle strengh by a grip test,
* measurement of muscle mass by impedancemetry,
* 4-meter walking speed test,
* Timed Up and Go (TUG) test,
* ADL and IADL questionnaires.
Study:
NCT04827758
Study Brief:
Protocol Section:
NCT04827758